arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Clover Health Investments, Corp.

CLOV Health Care Medical Specialities
$4.23
▼ -0.6% Today
as of Sep 4, 16:47 ET
Last 30 days -1.85% Jul 28 → Sep 04
$4.05 $4.24 $4.43 $4.62 $4.81 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$4.23
High
$4.29
Low
$4.22
Volume
$2M
Avg Vol
$7M
Mkt Cap
$2.4B
P/E (TTM)
42.55
Beta
—
52w High
$5.59
52w Low
$1.58
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 22 items

Sep 3 · 10:19 Insider Monkey
Clover Health (CLOV) Turns Profitable As Medicare Membership Explodes
Aug 31 · 20:05 PR GlobeNewswire
Clover Health to Participate in Upcoming Investor Conferences
Aug 28 · 10:23 Simply Wall St.
Clover Health Stock Stands Out Among Financially Fit Penny Stocks
▸ Show all 22 press releases & news Free account →

Overview

52-week range
$1.58
$5.59
66% of range
Avg surprise (last 3)
+72.2%
Avg reaction (last 2)
+1.3%
50% positive
Latest IV / EM
321%
EM ±13.4% · $5 · Sep 4

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.15$-0.10$-0.05$0.00$0.05 Actual $-0.15Actual $-0.06Actual $-0.09Est $-0.07Actual $-0.02Est $-0.04Actual $0.05Est $0.03Actual $0.05 MarJunSepMar/2025Jun/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-24M$178M$381M$584M$787M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $0.05 — — — — financials
Wed May 6, 2026Mar/2026 $0.05 $0.03 +66.7% — +2.7% earnings
Tue Aug 5, 2025Jun/2025 $-0.02 $-0.04 +50.0% — — earnings
Tue May 6, 2025Mar/2025 — $-0.07 +100.0% — 0.0% earnings
Sat Sep 30, 2023Sep 2023 $-0.09 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.06 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.15 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$743M$749M—$497M$478M$462M—$331M
Cost of revenue————————
Gross profit———————$81M
Operating income$28M$27M—$-24M$-11M$-1M—$-9M
Net income$28M$27M—$-24M$-11M$-1M—$-9M
EPS (diluted)$0.05$0.05——$-0.02———

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents———————$288M
Inventory————————
Total current assets$485M$448M$308M$331M$363M$331M$343M$433M
Total assets$720M$698M$541M$560M$575M$584M$581M$653M
Long-term debt————————
Total liabilities$344M$358M$232M$219M$231M$248M$240M$311M
Total equity$376M$339M$309M$341M$344M$336M$341M$342M

Implied volatility — last 90 days

37%108%179%250%320% Jun 07 — IV 77% · EM ±7.2%Jun 08 — IV 78% · EM ±6.5%Jun 09 — IV 130% · EM ±9.4%Jun 10 — IV 118% · EM ±7.0%Jun 11 — IV 124% · EM ±5.2%Jun 15 — IV 104% · EM ±7.5%Jun 16 — IV 72% · EM ±4.3%Jun 17 — IV 123% · EM ±5.1%Jun 19 — IV 70% · EM ±7.7%Jun 22 — IV 87% · EM ±7.2%Jun 23 — IV 81% · EM ±5.8%Jun 24 — IV 105% · EM ±6.2%Jun 25 — IV 218% · EM ±9.1%Jun 29 — IV 54% · EM ±12.8%Jun 30 — IV 78% · EM ±18.1%Jul 01 — IV 91% · EM ±3.8%Jul 03 — IV 38% · EM ±4.2%Jul 06 — IV 76% · EM ±6.3%Jul 07 — IV 61% · EM ±4.4%Jul 08 — IV 84% · EM ±5.0%Jul 09 — IV 113% · EM ±4.7%Jul 13 — IV 73% · EM ±6.1%Jul 14 — IV 90% · EM ±6.5%Jul 15 — IV 90% · EM ±5.3%Jul 16 — IV 97% · EM ±4.1%Jul 20 — IV 78% · EM ±6.5%Jul 21 — IV 82% · EM ±6.0%Jul 22 — IV 106% · EM ±6.3%Jul 23 — IV 69% · EM ±2.9%Jul 27 — IV 94% · EM ±7.8%Jul 28 — IV 138% · EM ±10.0%Jul 29 — IV 180% · EM ±10.6%Jul 30 — IV 188% · EM ±7.8%Aug 03 — IV 152% · EM ±12.7%Aug 04 — IV 153% · EM ±11.1%Aug 05 — IV 199% · EM ±11.8%Aug 06 — IV 126% · EM ±5.3%Aug 10 — IV 82% · EM ±6.9%Aug 11 — IV 65% · EM ±4.7%Aug 12 — IV 67% · EM ±4.0%Aug 13 — IV 56% · EM ±2.3%Aug 17 — IV 86% · EM ±7.1%Aug 18 — IV 99% · EM ±7.1%Aug 19 — IV 132% · EM ±7.8%Aug 20 — IV 85% · EM ±3.5%Aug 24 — IV 65% · EM ±5.4%Aug 25 — IV 80% · EM ±5.8%Aug 26 — IV 187% · EM ±11.1%Aug 27 — IV 260% · EM ±10.9%Aug 31 — IV 156% · EM ±13.0%Sep 01 — IV 196% · EM ±14.2%Sep 02 — IV 166% · EM ±9.8%Sep 03 — IV 321% · EM ±13.4%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in